Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. ultraeasy

UltraEASY

Computer Aided Multispectral Ulstrasound Diagnostic Device

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0
 Outcomes and results

 UltraEASY project word cloud

Explore the words cloud of the UltraEASY project. It provides you a very rough idea of what is the project "UltraEASY" about.

mobility    flexibility    mobile    preventatively    camud    therapeutic    ultrasound    risk    diagnostic    global    europeans    brain    aided    monitoring    waves    emergency    36    diagnosing    carriers    continuous    patient    time    computer    market    damage    acquisition    clinical    trade    feedback    groups    version    helicopters    incidents    acceptance    frequencies    realization    ambulances    multispectral    ultraeasy    interpretable    neuropathologies    daily    first    beginning    amounts    things    vehicles    conclude    2006    precise    modern    units    molecular    patients    underlying    diagnosis    stroke    multiple    immense    insurance    ag    strategies    family    clinics    evaluation    wake    feasibility    frame    ing    fast    medtech    sonovum    diagnose    thanks    practices    specialist    validation    harmful    events    killing    markets    regard    acoustics    acute    basic    small    diagnostics    conduct    someone    seconds    therewith    tissue    eur    initial    invasive    physicians    billion    health    final    economic    rescue    suffers    stands    every    examination    vitals    suited    innovation   

Project "UltraEASY" data sheet

The following table provides information about the project.

Coordinator		 SONOVUM AG 

Organization address
address: PERLICKSTRASSE 5
city: LEIPZIG
postcode: 4103
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Germany [DE]
 Project website http://www.sonovum.de
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2015
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-07-01   to  2015-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    SONOVUM AG DE (LEIPZIG) coordinator 50˙000.00

Map

 Project objective

Every 40 seconds, someone in Europe suffers from a stroke killing 1,000 Europeans daily. The resulting economic damage is immense. In the 2006 wake-up-study funded by the EU the economic damage in Europe amounts to 36 billion EUR per year. The objective of this project is the clinical validation of SoNovum AG’s UltraEASY™ II Brain Vitals Monitoring System and the underlying CAMUD technology for diagnosing and monitoring neuropathologies in acute events and at-risk patient groups. CAMUD stands for “Computer Aided Multispectral Ultrasound Diagnostics” and is a novel diagnostic method based on molecular acoustics. It measures the feedback of ultrasound waves on multiple frequencies, which is interpretable for the first time thanks to modern computer technology. The technology enables, among other things, a fast, very precise and non-invasive diagnosis of the brain tissue in the beginning of the therapeutic time frame as well as further, continuous monitoring. Therewith physicians will be able to diagnose acute events more quickly and preventatively at-risk patient groups, even before harmful incidents occur. Initial target market groups for UltraEASY II include the stroke units in clinics as well as family and specialist's practices in Europe with regard to global markets as well. Because of high mobility, flexibility and the small acquisition costs, it is well suited as basic equipment for practices as well as, in its mobile version, for helicopters, rescue vehicles and ambulances of clinics and emergency organizations. The objectives of this Feasibility Study are the examination of the market acceptance towards UltraEASY II, addressing clinics and physicians as well as involving patients, patient organizations and health insurance carriers, in order to conduct the risk evaluation for the final realization of the CAMUD technology in the MedTech sector and conclude the development of final innovation strategies for Phase 2.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ULTRAEASY" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ULTRAEASY" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

HELP (2019)

Collaboration for innovation: Establishment of a pan-nematode drug development platform

Read More  

HAP2 (2020)

Host-targeted Approaches for the Prevention and the treatment of Hospital-Acquired Pneumonia

Read More  

MISTRAL (2020)

Microbiome-based stratification of individuals at risk of HIV-1 acquisition, chronic clinical complications,antimicrobial drug resistance,and unresponsiveness to therapeutic HIV-1 vaccination

Read More